Skip to Main Content

An official website of the United States government

Government Funding Lapse

Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit  cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at OPM.gov.

THORAX

Principal Investigator
Name
Eleftherios Trivizakis
Degrees
Ph.D.
Institution
Foundation for Research and Technology - Hellas
Position Title
Research Scientist
Email
About this CDAS Project
Study
NLST (Learn more about this study)
Project ID
NLST-1312
Initial CDAS Request Approval
Aug 28, 2024
Title
THORAX
Summary
The joint venture of THORAX consists of several clinical sites including research institutes and private sector pharmaceutical businesses around Greece. Numerous artificial intelligence (AI) models will be developed to detect, delineate, classify malignancies, and provide innovative prognostic AI models for lung nodules. In a blinded method, three groups of radiologists, each representing a different group, annotate the thoracic CT scan to detect and describe any worrisome nodules. Furthermore, three cohorts of oncologists gather the electronic health record (including biopsies, pathology images, tabular data, laboratory data, etc.) of a specific subgroup of patients classified as having lung cancer within the same population. This initiative possesses the capacity to establish the groundwork for a more extensive screening program in Greece. The inclusion of the NSLT dataset will enhance our existing dataset and facilitate the development of fundamental models for further advancement in lung cancer differentiation.

THORAX is funded by AstraZeneca Hellas.

URL: https://thorax.pagni.gr/
Aims

The objective of the project is to establish an artificial intelligence (AI)-driven screening system that may be implemented in small countries with limited resources, characterized by challenges in recruiting medical specialists for their national health system. Moreover, Greece's terrain presents a formidable obstacle, as small islands or mountainous cities impede the presence of skilled radiologists. Artificial intelligence has the capacity to democratize healthcare by helping to close the divide between large urban centers and remote rural regions.

Collaborators

-Foundation for Research and Technology - Hellas, Institute of Computer Science (ICS-FORTH), Heraklion, Greece
-University Genetal Hospital of Heraklion "PAGNI", Heraklion, Greece
-Sotiria Thoracic Diseases Hospital of Athens, Athens, Greece
-"George Papanikolaou" General Hospital of Thessaloniki, Thessaloniki, Greece
-AstraZeneca Hellas, Athens, Greece